Spring 2026: We get Orforglipron
In December 2025, CMS announced the Medicare GLP-1 Bridge demonstration, a short-term program that will allow eligible Medicare beneficiaries to access GLP-1 obesity medications at a $50/month co-pay starting July 2026 , using a centralized processor to manage PA, claims adjudication, and payment ( [18] )
95% CI, 0.75 to 1.23) or the rate of death (HR, 0.94
Stimulation of PI hydrolysis in response to OA (10 M), however, was significantly inhibited in cells transfected with PLC- siRNA (72 5% inhibition) (Figure 4)
Constipation ICD-10 Codes: Complete Guide for Accurate Coding Dr
Most importantly, hes someone who believes every American deserves clear, honest information without pressure.